search
Back to results

Diabetes Prevention and Prediabetes Management in Adult (PRIME)

Primary Purpose

PreDiabetes

Status
Active
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
Digital health supported
Usual care
Sponsored by
Monash University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for PreDiabetes focused on measuring Digital Health, Mobile Health, Lifestyle Program, Prediabetes

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 18 years and above
  • BMI 23 and above
  • HbA1c 5.7 - 6.3%

Exclusion Criteria:

  • Unable to give informed consent
  • Pregnant or lactating
  • Established diabetes
  • Terminal illness
  • Does not own a mobile phone
  • Plans to relocate to an area or travel plans that do not permit full participation in the study

Sites / Locations

  • School of Pharmacy

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention arm

Usual care arm

Arm Description

Participants receiving the phone app together with a fitness tracker. All participants will receive the educational curriculum over a period of 4 weeks through the app. The mobile app allows secure patient monitoring through a participant dashboard that the coach can use to increase patient adherence and motivation to achieve goals. The participant can use the app to log their food intake, weight, steps, exercise, in addition to participating in the peer support via the chat function. Participants will also receive regular care and follow up in community pharmacies for support.

The control group will be a "usual care" condition in which participants are free to seek any assistance for their medical care during the study period. Participants will be given physical tracking sheets to record their food intake, weight, steps and exercises.

Outcomes

Primary Outcome Measures

Feasibility of mobile app assessed by the engagement rate with the mobile app
Engagement rate with the mobile app will be measured via time spend on using the app functions, measured in hours.
Acceptability of mobile app assessed by a semi-structured interview
Semi-structured interview focusing on users experience will be conducted post-intervention.

Secondary Outcome Measures

Change in health related quality of life as accessed by EuroQol (EQ-5D-5L)
The questionnaire assess patient's health state in 5 dimensions- anxiety/depression, mobility, self-care, usual activities, pain/discomfort. Each dimension can be scored from 1 - 5, summing up to a total score of between 5 - 25. A lower score representing a better health state.
Change in dietary practice
3-Day diet recall to assess changes in food intake
Change in physical activity
Physical Activity Questionnaire (short form) (IPAQ) to obtain internationally comparable data on health-related physical activity. Time spent on physical activities will be measured and converted into metabolic equivalent for task (MET). A lower MET indicates a lower physical activity level.
Change in blood pressure
Systolic and diastolic pressures will be collected during the study period, unit in mmHg
Change in lipid profile
HDL, LDL, triglycerides and total cholesterol levels will be collected, unit in mmol/L
Change in knowledge, attitude and practice towards prediabetes
Knowledge Attitude Practice-Prediabetes Assessment Questionnaire (KAP-PAQ) questionnaire will be administered pre- and post intervention. The minimum total score is 14 while the maximum total score is 91. A higher score indicating a better knowledge, attitude and practice.
Change in weight
Weight Loss by % of change and total weight change (kg).
Change in body fat composition
Body fat composition change measured in % change.
Change in waist-to-hip ratio
Waist circumference and hip circumference measured in centimetres.

Full Information

First Posted
December 15, 2021
Last Updated
March 17, 2023
Sponsor
Monash University
Collaborators
Caring Pharmacy, Bionime Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT05214209
Brief Title
Diabetes Prevention and Prediabetes Management in Adult
Acronym
PRIME
Official Title
Addressing Disparity in Diabetes Prevention Through Digital Health Supported PRe-diabetes Intervention, Management and Evaluation (PRIME) Program Based in Malaysian Community Pharmacies: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 1, 2022 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Monash University
Collaborators
Caring Pharmacy, Bionime Corporation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Currently, an estimated 3.9 million Malaysians continue to live with diabetes with many more who live with prediabetes. Diabetes was the one of the leading causes of death in the Malaysia and the leading cause for kidney failure, lower-limb amputations, and adult-onset blindness. Heart disease and stroke are two to four times more likely for individuals with diabetes. The use of mHealth or mobile health application can reduce blood sugar among individuals with prediabetes but also prevent a later occurrence of diabetes. In this study, the investigators aim to develop and evaluate the effectiveness of a digital health supported pre-diabetes management program based in an urban community pharmacy setting
Detailed Description
Pre-diabetes is an intermediate state of hyperglycaemia with glycaemic parameters above normal but below the type 2 diabetes mellitus (T2DM) threshold. It was estimated that >25% of individuals who are pre-diabetic convert to T2DM within 3-5 years and 70% of individuals with pre-diabetes will develop into full-fledge T2DM within their lifetimes. According to the 2017 estimate, the disease burden of pre-diabetes at Western Pacific region was 7.6% (126.7 millions). The situation is more alarming in Malaysia where a national pre-diabetes prevalence of 22.1% was noted. Currently available support and self-care services offered in Public Hospitals such as the Diabetes Mellitus Treatment Adherence Clinics (DMTAC) are managed based on the in-person appointment basis. Most of the clinics are available only in specific locations. The need to travel long distance as well as long waiting hours has deterred the success of the programs. This is particularly true for the urban poor who are less likely to take time off from work than those from the higher income group. It is also noteworthy to state that the management program when available, generally target the diagnosed T2DM patients. Studies have shown that individuals with pre-diabetes can substantially reduce their risk of progression to T2DM via participation in evidence-based lifestyle change programs. Previous reports have recorded 54-58% reduction in risk for development to T2DM over 1-3 years with the protective benefit persisting up to 10 years following completion of the program. However, there are several considerations when implementing effective lifestyle intervention program among the pre-diabetes populations in Malaysia. The intervention program should easily be accessible and not confined to public primary and secondary healthcare centres which are already suffering from an overcapacity. Furthermore, consultation should be provided by properly trained healthcare professionals while the ease of communication between the patients and the "lifestyle coach" should be made available. The advancement of information technology coupled with the increasing availability and acceptance of internet and mobile devices provide useful opportunities for application of wireless and mobile technology in order to enhance self-management of chronic conditions. The incorporation of digital technologies can improve patient adherence and facilitate real-time monitoring of vital biological measurements (i.e. via wearable). Additionally, the "mobile health" (mHealth) services are easily scalable, thus providing opportunities to a greater public accessibility and narrow the disparity in access to disease management. In this study, the investigators propose to pilot a digital health supported pre-diabetes management program based in an urban community pharmacy setting

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PreDiabetes
Keywords
Digital Health, Mobile Health, Lifestyle Program, Prediabetes

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
Cluster randomisation with blinding of statisticians
Allocation
Randomized
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention arm
Arm Type
Experimental
Arm Description
Participants receiving the phone app together with a fitness tracker. All participants will receive the educational curriculum over a period of 4 weeks through the app. The mobile app allows secure patient monitoring through a participant dashboard that the coach can use to increase patient adherence and motivation to achieve goals. The participant can use the app to log their food intake, weight, steps, exercise, in addition to participating in the peer support via the chat function. Participants will also receive regular care and follow up in community pharmacies for support.
Arm Title
Usual care arm
Arm Type
Active Comparator
Arm Description
The control group will be a "usual care" condition in which participants are free to seek any assistance for their medical care during the study period. Participants will be given physical tracking sheets to record their food intake, weight, steps and exercises.
Intervention Type
Behavioral
Intervention Name(s)
Digital health supported
Intervention Description
Participants will be issued a fitness tracker, a Bluetooth enabled glucometer, and a custom developed app which they can communicate digitally to the study investigators either as a group or individually. In the beginning of the study, participants will be taught on how to use the program, how to interact with their coach, and the importance of maintaining motivation throughout the program. Participants will have access to a pharmacist-participant messaging, group messaging, daily challenges for behavior change, education articles (weekly bite-sized content over 4 weeks), food logging, steps and exercise logging, and feedback. They will be asked to log their weight, meals, and physical activity within the program on a weekly basis. Pharmacist will monitor participant progress through a web-based dashboard. Community pharmacist will be assisting users in setting specific, measurable, attainable, realistic, and time-based goals on a weekly basis.
Intervention Type
Behavioral
Intervention Name(s)
Usual care
Intervention Description
Participants will be issued a fitness tracker and Bluetooth enabled glucometer but these functions will not be enabled or linked to any app. All participants will be given physical tracking sheets to log in their food intake, blood glucose levels and food diary but will not have access to a personal coaching. Participants are free to seek any assistance for their medical care during the study period.
Primary Outcome Measure Information:
Title
Feasibility of mobile app assessed by the engagement rate with the mobile app
Description
Engagement rate with the mobile app will be measured via time spend on using the app functions, measured in hours.
Time Frame
1 month
Title
Acceptability of mobile app assessed by a semi-structured interview
Description
Semi-structured interview focusing on users experience will be conducted post-intervention.
Time Frame
1 month
Secondary Outcome Measure Information:
Title
Change in health related quality of life as accessed by EuroQol (EQ-5D-5L)
Description
The questionnaire assess patient's health state in 5 dimensions- anxiety/depression, mobility, self-care, usual activities, pain/discomfort. Each dimension can be scored from 1 - 5, summing up to a total score of between 5 - 25. A lower score representing a better health state.
Time Frame
Baseline, 1 month
Title
Change in dietary practice
Description
3-Day diet recall to assess changes in food intake
Time Frame
Baseline, 1 month
Title
Change in physical activity
Description
Physical Activity Questionnaire (short form) (IPAQ) to obtain internationally comparable data on health-related physical activity. Time spent on physical activities will be measured and converted into metabolic equivalent for task (MET). A lower MET indicates a lower physical activity level.
Time Frame
Baseline, 1 month
Title
Change in blood pressure
Description
Systolic and diastolic pressures will be collected during the study period, unit in mmHg
Time Frame
Baseline, 1 month
Title
Change in lipid profile
Description
HDL, LDL, triglycerides and total cholesterol levels will be collected, unit in mmol/L
Time Frame
Baseline, 1 month
Title
Change in knowledge, attitude and practice towards prediabetes
Description
Knowledge Attitude Practice-Prediabetes Assessment Questionnaire (KAP-PAQ) questionnaire will be administered pre- and post intervention. The minimum total score is 14 while the maximum total score is 91. A higher score indicating a better knowledge, attitude and practice.
Time Frame
Baseline, 1 month
Title
Change in weight
Description
Weight Loss by % of change and total weight change (kg).
Time Frame
Baseline, 1 month
Title
Change in body fat composition
Description
Body fat composition change measured in % change.
Time Frame
Baseline, 1 month
Title
Change in waist-to-hip ratio
Description
Waist circumference and hip circumference measured in centimetres.
Time Frame
Baseline, 1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18 years and above BMI 23 and above HbA1c 5.7 - 6.3% Exclusion Criteria: Unable to give informed consent Pregnant or lactating Established diabetes Terminal illness Does not own a mobile phone Plans to relocate to an area or travel plans that do not permit full participation in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shaun Lee, PhD
Organizational Affiliation
Monash University Malaysia
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Chun Wie Chong, PhD
Organizational Affiliation
Monash University Malaysia
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Pharmacy
City
Subang Jaya
State/Province
Selangor
ZIP/Postal Code
47500
Country
Malaysia

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
We plan to share any related individual participant data within reasonable request which can be obtained from the principal investigators

Learn more about this trial

Diabetes Prevention and Prediabetes Management in Adult

We'll reach out to this number within 24 hrs